NCT00531973 - A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

December 31, 2009

Conditions

Breast Cancer

Interventions

DRUG

liposomal doxorubicin

5-fluorouracil (500 mg/m²) + pegylated liposomal doxorubicin (50 mg/m²) + cyclophosphamide (500 mg/m²) + adjuvant radiation therapy ± endocrinological therapy (FalipoC)

DRUG

epirubicin

5-fluorouracil (500 mg/m²) + epirubicin (90 mg/ m²) + cyclophosphamide (500 mg/ m²) + adjuvant radiation therapy ± endocrinological therapy (FEC90)

Trial Locations (1)

00168

RECRUITING

Catholic University, Rome